Company intelligence / Profile preview

Tecnoss

Ownership: Private
Development stage: Other

Overview

Tecnoss' OsteoBiol products are CE marked, commercially available, and supported by clinical use for dental and maxillofacial bone and tissue regeneration, with evidence demonstrating biocompatibility and effective gradual resorption, closely mimicking autologous bone healing[1][2][3][5][8].

Therapeutic areas: Other
Modalities: BiologicCollagen-based medical deviceXenogeneic biomaterial
Industry: Surgical Medical Devices

Partnerships

Distributors in over 60 countriesCollaborations with public and private research centers[1]

Beyond the preview

Go deeper on Tecnoss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tecnoss.